Hormone therapy drugs have carried box warning labels for years. Food and Drug Administration Commissioner Marty Makary talks with NPR about why the agency is removing them.
FDA Commissioner Martin Makary speaks during an event about drug prices with President Donald Trump, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington. (AP Photo/Evan Vucci) ...
The Federal Food and Drug Administration’s recommendation is that the lowest effective dose be used for the shortest possible duration.
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...
Says “doesn’t know” what’s behind the FDA’s claims that the Covid vaccine killed 10 children, commenting that “to be honest, we haven’t seen any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback